戻る Agenda
Session 7, Track B: Translating ICH E6(R3) into Action - Perspectives from Regulators, Sponsors, and Operational Teams
Session Chair(s)
Foo-Lim Yeh
Allergan Aesthetics, Neuroscience, and Specialty Head, Regulatory Affairs, AbbVie, Canada
Nessrine Hanna, MSc
Director, Clinical Operations, AbCellera, Canada
Session 7, Track B: Translating ICH E6(R3) into Action - Perspectives from Regulators, Sponsors, and Operational Teams
Speaker(s)
Kathy Heard, MSc
VP ClinOps and Safety, NoNO Inc, Canada
Case Study: Application of ICH e6(R3) Principles in Conducting Centralized Monitoring and Quality Review